SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NVS: Novartis AG -- Ignore unavailable to you. Want to Upgrade?


To: Alfred W. Post who wrote (63)6/15/2001 8:37:41 AM
From: Alfred W. Post  Read Replies (1) | Respond to of 116
 
Just got news from the firm that they filed with the EMEA (Europ. Medicines Evalu. Agency)a novel treatment for atopic eczema wich can be applied for kids as young as several months only and seems to be a novum. Again does anybody konw the significants of this? If you want the full text send your e-mail address to alfred.post@datazug.ch and I will send it and if wanted also previous relieces to you. Fred